Solstice Capital

Solstice Capital seeks superior venture capital returns for its limited partners through investments in seed- and early-stage companies in

Business Model:

Revenue: $8.4M

Employees: 2-10

Rankings

Detailed Solstice Capital Information

Geographic Data

Solstice Capital headquarters map

Address: 81 Washington St

City: Salem

State: MA

Zip: 01970

Country: US

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$0

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Solstice Capital seeks superior venture capital returns for its limited partners through investments in seed- and early-stage companies in the industry areas of alternative energy, education, the environment, life sciences and information technology. Solstice&s;s unique assets give it a distinct advantage: a seasoned management team with over 90 years of experience in both venture investing and operations in high-growth companies an emphasis on positive impact investing the appropriate size fund for early-stage companies geographic diversification From its inception, Solstice has demonstrated its commitment to provide both capital and expert guidance to assist portfolio companies as they deal with the challenges and opportunities of growth. An early-stage, diversified, positive impact venture fund Solstice is committed to investing 50% of its capital in information technology and 50% in the following socially responsive investment categories: Alternative Energy The Environment Life Sciences Education

Contact Phone:
+16175237733

Contact Email:

Announced Date Company Transaction Money Raised
2/2002 E Ink Venture Round 15M
4/2006 PhotoThera Series C 30.5M
4/2005 Protonex Technology Corporation Series B 0
10/2005 HTG Molecular Diagnostics Series B 3.4M
5/2018 Splash Pharmaceuticals Series D -
3/2003 Lumigent Technologies Venture Round 7M
1/2008 AmpliMed Corporation Series C 0
10/2007 HTG Molecular Diagnostics Series C 0
8/2006 Regenesis Biomedical Series B 0
9/2003 HTG Molecular Diagnostics Series A 156k
4/2002 HTG Molecular Diagnostics Series A 1.3M
9/2005 Carefx Series B -
9/2003 AmpliMed Corporation Series A 5M
6/2005 AmpliMed Corporation Series B 5M
9/2005 MetaCarta Series C 10M
4/2004 Astoria Software Series A 11.4M
10/2005 Carefx Series B 12.3M
5/2008 Regenesis Biomedical Series B 0
6/2004 Unveil Technologies Venture Round 6.5M
5/2003 Unveil Technologies Series A 7.5M
3/2006 CodeRyte Series C 0
2/2006 Archivas Series C 12M
7/2011 HTG Molecular Diagnostics Series D 0
4/2003 Supplyworks Venture Round 3M
10/2005 Lumidigm Series B 8.1M
6/2003 StrionAir Series A 5M
10/2004 StrionAir Series B 11M
11/2008 CodeRyte Series D 0
8/2000 Sequencia Venture Round 0
11/2008 HTG Molecular Diagnostics Series C 0
12/2004 Archivas Series B 10M
8/2003 Arxan Technologies Series B 8.3M
6/2005 Protonex Technology Corporation Series C 11M
3/2004 E Ink Venture Round 8.1M
9/2001 Okena Series B 12.4M
1/2004 MetaCarta Series B 6.5M
6/2011 Regenesis Biomedical Series C 0
3/2007 Arxan Technologies Series C 0
12/2005 E Ink Venture Round 0
3/1996 I2 Technologies Seed Round -
6/2001 Connected Corporation Venture Round 0
5/2004 AmpliMed Corporation Series A 4.3M
3/2004 Protonex Technology Corporation Series A -
7/2003 Carefx Series A 7.2M
9/2002 CellzDirect Venture Round 3.4M
1/2008 Lumidigm Series C 0
10/2005 PhotoThera Series B 19M
5/2018 Splash Pharmaceuticals Series D -
7/2011 HTG Molecular Diagnostics Series D 0
6/2011 Regenesis Biomedical Series C 0
11/2008 HTG Molecular Diagnostics Series C 0
11/2008 CodeRyte Series D 0
5/2008 Regenesis Biomedical Series B 0
1/2008 Lumidigm Series C 0
1/2008 AmpliMed Corporation Series C 0
10/2007 HTG Molecular Diagnostics Series C 0
3/2007 Arxan Technologies Series C 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research